Real-world outcomes of advanced NSCLC patients with common and uncommon/complex EGFR mutation profiles Published September 2019 Citation Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC. . World Conference on Lung Cancer. . Authors:Riely, GJ, Lovly, CM, Messina, CGM, Bienert, S, Alexander, K, Pao, W, Magee, K, Baxi, SS, Doebele, RC Sources:World Conference on Lung Cancer Share Posted inPublicationsUnmet need More publicationsISPORApril 2026Impact of telemedicine encounters on survival outcomes in advanced lung cancer: A time-varying cox analysis using EHR-derived dataParatane D, Adamson B, Zemplenyi APublication summaryPublicationsNon-small cell lung cancerISPORApril 2026Real-world (RW) treatment patterns and outcomes in patients with =2 lines of therapy (LOTS) for recurrent or progressive endometrial cancerBhak R, Iyer NN, Hopkins A, et al.Publication summaryPublicationsTreatment patternsAdvanced endometrial cancerISPORApril 2026From real-world data (RWD) to digital twins: building models for patient-level counterfactual prediction in oncologyGriffith S, Manfredonia J, Ricottone M, et al.Publication summaryPublicationsMachine learningNon-small cell lung cancerArtificial intelligence